Provita Profamilia

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Bladder cancer1 trial
• Head and neck cancer1 trial
• Prostate cancer1 trial

Phase

• Phase 32 trials
• Phase 2/31 trial

Status

• Active, not recruiting3 trials

Lead sponsor

• AstraZeneca1 trial
• Eli Lilly and Company1 trial
• Inhibrx Biosciences, Inc1 trial

Running trials

• Recruiting

  Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)

  NCT06295731· Phase 2/3· Inhibrx Biosciences, Inc· Source

  Contact: Study Director - Inhibrx

• Active, not recruiting

  A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)

  NCT05288166· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder Cancer

  NCT03528694· Phase 3· AstraZeneca· Source